Contact Us Today
877.534.5750

  • AsbestosDiseases

    Serious Injuries Reported

    Important Information

    for anyone who was exposed to asbestos.

    Read More
  • WageCompensation

    Not Paid For Hours Worked?

    Important Information

    for people who worked and were not properly paid for hours worked.

    Read More
  • IVCFilters

    IVC Filters Linked to Serious Injuries

    Important Information

    for people who have an IVC Filter or other blood clot device.

    Read More
  • 1
  • 2
  • 3

Free Case Evaluation

To obtain a free case evaluation, select from the options below. Choose the type of case evaluation which best matches your need.
One of our firm representatives will be in contact with you to further discuss your possible claim.

AkinMears Insider

  • Botched French Drug Trial Leaves Patient Dead Monique Turner Feb-12-2016

    A routine Phase I clinical trial in France resulted in the hospitalization of 5 participants and the death of another. The trial was immediately halted when the participants began showing signs of brain damage days after receiving multiple daily doses of the drug. One volunteer was declared brain dead and died a week later. Approved by France’s National Agency for Medicine and Health Products Safety in June of 2015, the trial was meant to test the drug in varying degrees of dosages in healthy...

    Read More...

  • FDA Revises Diabetes Drug Labels to Include Additional Warnings Monique Turner Feb-09-2016

    The U.S. Food and Drug Administration added warnings about the risk of ketoacidosis and serious urinary tract infections to labels of type 2 diabetes drugs, such as Invokana, Invokamet, and Farxiga. These drugs, known as sodium glucose cotransporter-2 (SGLT2) inhibitors, work by lowering blood glucose levels allowing for glycemic control, as well as the reduction of body weight and blood pressure.  The additional warnings come after an initial Drug Safety Communication alert concerning the risk...

    Read More...

  • FDA to Review Essure Birth Control Devices Monique Turner Feb-03-2016

    A November update from the U.S. Food and Drug Administration anticipates plans to release their findings on the contraceptive implant Essure by the end of February 2016. The communication outlines the FDA’s evaluation of the device, which includes reviewing information from medical literature, adverse events reports, and the testimony of those who participated in the public September meeting of the Obstetrics and Gynecology Devices Panel.  Designed as a less invasive alternative to tubal...

    Read More...

  • Congress Approves Child-Proof Packaging for E-Cigs Gabraella King Feb-01-2016

     Photo: Getty Images A rise in nicotine poisoning incidents in young children has allowed Congress to pass legislation requiring child-proof packaging on bottles of liquid nicotine used in e-cigarettes. As the popularity of e-cigarettes has grown to an estimated $3.5 billion in sales since 2010, the number of child nicotine poisonings has also dramatically increased. According to the American Association of Poison Control Centers, poisoning cases have climbed from 271 in 2011 to 3,783 in 2014....

    Read More...

  • Popular Acid Reflux Drugs Are Linked to Kidney Disease Gabraella King Jan-27-2016

     Photo: Getty Images A study in the Journal of the American Medical Association Internal Medicine suggests that popular medications used to treat heartburn, indigestion, and acid reflux may lead to increased risk for kidney disease. The study examined the medical records of over 250,000 people, reviewing data from 10,482 participants in an Atherosclerosis Risk in Communities study coupled with 248,751 patients in the Geisinger Health System. The researchers found patients using the drugs known...

    Read More...

© 2015. All rights reserved. Various trademarks held by their respective owners. AkinMears, G.P., 5847 San Felipe St., 45th FL, Houston, TX 77057 
281-803-5750 or Toll Free 877-534-5750 While we retain joint responsibility, most cases of this nature are referred to other attorneys for principal responsibility.